ArticlebioRxiv : the preprint server for biology2025
A Precisely Controlled Long-Acting Immunosuppression Platform Enables Prolonged Survival of Vascularized Composite Allografts.
Sohyung Lee et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.